Abstract
Context: The International Association for the Study of Pain (IASP) defines chronic pain as pain that persists or recurs for longer than 3 months. Chronic pain has a significant global disease burden with profound effects on health, quality of life, and socioeconomic costs. Evidence Acquisition: Narrative review. Results: There are several treatment options, including pharmacological therapy, physical rehabilitation, psychological therapies, and surgical interventions, for chronic pain management. Magnesium has been FDA-approved for several indications including hypomagnesemia, arrhythmia, prevention of seizures in eclampsia/preeclampsia, and constipation. Magnesium has been used for numerous off-label uses, notably for acute and chronic pain management. The mechanism of magnesium in pain management is primarily through its action as a voltage-gated antagonist of NMDA receptors, which are involved in pain transduction. Conclusions: This narrative review will focus on the current evidence and data surrounding the utilization of magnesium as a treatment option for chronic pain.
Original language | English (US) |
---|---|
Article number | e112348 |
Pages (from-to) | 1-10 |
Number of pages | 10 |
Journal | Anesthesiology and Pain Medicine |
Volume | 11 |
Issue number | 1 |
DOIs | |
State | Published - Feb 2021 |
All Science Journal Classification (ASJC) codes
- Anesthesiology and Pain Medicine